Optimized 2-methoxyestradiol invasomes fortified with apamin: a promising approach for suppression of A549 lung cancer cells

• Main Authors: Zuhier A. Awan (Author), Shareefa A. AlGhamdi (Author), Nabil A. Alhakamy (Author), Solomon Z. Okbazghi (Author), Mohamed A. Alfaleh (Author), Shaimaa M. Badr-Eldin (Author), Hibah M. Aldawsari (Author), Mohammed A. S. Abourehab (Author), Hani Z. Asfour (Author), Shadi A. Zakai (Author), Mohammad W. Alrabia (Author), Aya A. Negm (Author), Mohamed A. El-Moselhy (Author), Sara S. Sharkawi (Author), Waleed Y. Rizg (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Certain anticancer agents selectively target the nucleus of cancer cells. One such drug is 2-methoxyestradiol (2ME), which is used for treating lung cancer. To improve the therapeutic effectiveness of these agents, many new methods have been devised. 2ME was entrapped into the core of hydrophobic in...